Related Experiment Video
Updated: May 6, 2026

Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
Psychopharmacologic management of serious behavioral disturbance in ASD
1Department of Psychiatry, Christian Sarkine Autism Treatment Center, Indiana University School of Medicine, Riley Hospital for Children, Room 4300, 705 Riley Hospital Drive, Indianapolis, IN 46202-5200, USA.
Abstract:
Individuals diagnosed with autism spectrum disorders (ASD) often exhibit serious behavioral disturbance (irritability) including severe tantrums, aggression, and self-injury that requires pharmacologic management. Research focused on the treatment of severe irritability has primarily involved the atypical antipsychotics, including risperidone and aripiprazole. Anticonvulsants have also been investigated for targeting serious behavioral disturbance; however findings have been mixed. Advances in the pharmacotherapy of irritability in ASD continue to inform practice. Research is needed to develop safer and more effective drug treatments for serious behavioral disturbance in this population.
More Related Videos
08:30Author Spotlight: Exploring Autism Spectrum Disorder Symptoms in Fruit Flies — Genetic Models and Behavioral Tests
Published on: September 6, 2024
08:42A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Drug Therapy
Antianxiety Medications
Behavior Modification
A real-world application of operant conditioning principles is applied...
Psychosis and Antipsychotic Drugs: Overview
Operant Conditioning Intervention
In operant conditioning, behaviors that are...